CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.56
−1.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.29x
- Price / sales
- 21.17x
- Price / cash flow
- -0.58x
Enterprise value
- Enterprise value
- $6.4M
- EV / sales
- 20.25x
- EV / EBITDA
- -0.56x
- EV / EBIT
- -0.52x
- Market cap
- $6.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026